iBio, Inc. (NYSEMKT:IBIO)

CAPS Rating: 1 out of 5

A bio-pharmaceutical company focused on the development and commercialization of novel plant-made products for the prevention and treatment of serious infectious diseases.

Results 1 - 6 of 6

Recs

1
Member Avatar jed71 (54.34) Submitted: 9/19/2014 3:57:37 PM : Underperform Start Price: $0.64 IBIO Score: +13.15

One of the heaviest promoted stocks in August. Popped recently and just became pickable again. Choosing a downthumb here, although this most certainly could run higher. Some information on the recent promoters:

Promoter: Moving Pennies Compensation: $3,000
Promoter: - On Time - Compensation: $2,500
Promoter: SmallCapStockPlays Compensation: $15,000

Here is a snippet from one of SmallCap StockPlays emails :

"Hi All,

Good Morning Traders

I hope that you're ready to do your research now, because we are giving you something truly special.

We've got something that is setting up to be a true MONSTER and we have YOU in on it FIRST!

Start your research on iBio, Inc. (IBIO) right away.

Priced at right at 38 cents, and with a shares outstanding of less than 66 million, IBIO is already a winner and is primed and ready for a monster run today.

The biggest key in this one is its super low float yet great share price, offering traders the opportunity to get in on this one early.

IBIO's technicals are more solid than what it looks. It has not been below .30 cents in over a year, suggesting that it is sitting on its level of support, waiting for the right moment to strike.

And... Today should be that day!"

Recs

0
Member Avatar GirlsUnder30 (96.04) Submitted: 1/2/2013 12:38:55 PM : Outperform Start Price: $0.64 IBIO Score: -50.20

In the growing field protein synthesis.The recent additions to the board and management should help them find customers and build partnerships.

Recs

1
Member Avatar 4thRockFool (24.90) Submitted: 7/8/2011 8:44:11 PM : Outperform Start Price: $2.40 IBIO Score: -140.88

Promising biotech startup that is commercializing technology developed by the Fraunhofer USA Center for Molecular Biotechnology (the German equivalent of the NIH). Great science that has the potential to revolutionize the manufacture of biopharmaceuticals. Their platform uses green plants to rapidly produce high levels of target proteins. This rapid scale up capability for production of vaccines was proven in the recent flu outbreak. iBio has already attracted sophisticated partners.

Recs

0
Member Avatar gregbledsoe (< 20) Submitted: 3/9/2011 12:20:13 PM : Outperform Start Price: $2.70 IBIO Score: -129.92

There is a chance, maybe not a big one, that this stock will do very well over time. There is also a chance, maybe a larger one, that this stock is a pump-n-dump. The stock is cheap - I'm thinking I'll take that risk and put a few dollars in it.

Recs

2
Member Avatar BillyDurant (< 20) Submitted: 1/14/2011 5:37:10 PM : Outperform Start Price: $6.06 IBIO Score: -145.09

This company owns a process which could very likely make existing vaccine making technology obsolete. That vaccine business is worth tens of billions. The market cap of this company is less than $150 million. Do the math.

Recs

0
Member Avatar venturacc (69.21) Submitted: 1/5/2011 7:44:04 PM : Outperform Start Price: $3.92 IBIO Score: -143.30

This stock has been relisted on the AMEX as IBIO.
I want to add it to my CAPS list but CAPS can not find IBIO. The stock closed today at 3.48.

Results 1 - 6 of 6

Featured Broker Partners


Advertisement